camptothecin has been researched along with luotonin a in 14 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 5 (35.71) | 29.6817 |
2010's | 7 (50.00) | 24.3611 |
2020's | 2 (14.29) | 2.80 |
Authors | Studies |
---|---|
Cagir, A; Eisenhauer, BM; Gao, R; Hecht, SM; Jones, SH | 2 |
Friedrich, TD; Guzzo, PR; Jason Herr, R; Nacro, K; Peace, D; Zha, CC | 1 |
Almansour, AI; Altaf, M; Arumugam, N; Bianchini, G; Ghabbour, HA; Mahalingam, SM; Menéndez, JC; Sau, S; Suresh Kumar, R | 1 |
He, C; He, M; Li, L; Liang, X; Luan, S; Lv, C; Song, X; Wu, Q; Yin, L; Yin, Z; Yuan, Z; Zhang, W; Zou, Y | 1 |
Battisti, V; Deckardt, S; Haider, N; Haller, AV; Heffeter, P; Ibric, A; Langer, T; Lee, C; Marian, B; Prötsch, C; Schueffl, HH | 1 |
Goon, S; Kundu, B; Mondal, MA; Sarkar, D; Talukdar, A | 1 |
Cheng, K; Eisenhauer, BM; Gao, R; Hecht, SM; Rahier, NJ; Thomas, SJ | 1 |
Liu, GS; Yao, ZJ; Zhou, HB | 1 |
Corda, E; Girotti, S; González-Ruiz, V; Martín, MA; Mussardo, P; Olives, AI | 1 |
Jahng, Y; Jeong, TC; Kim, DH; Lee, J; Lee, S | 1 |
Bianchini, G; Fernández-Marcelo, T; González-Ruiz, V; Iniesta, P; Martín, MA; Menéndez, JC; Olives, AI; Pascua, I; Ramos, MT; Ribelles, P; Sridharan, V | 1 |
Ayyanaar, S; Kesavan, MP; Kotla, NG; Kumar, GGV; Rajagopal, G; Rajesh, J; Sivaraman, G; Webster, TJ | 1 |
Almansour, AI; Altaf, M; Arumugam, N; Bianchini, G; Dupadahalli, K; Kumar, RS; Menéndez, JC; Mohammad, F | 1 |
2 review(s) available for camptothecin and luotonin a
Article | Year |
---|---|
A comprehensive review of topoisomerase inhibitors as anticancer agents in the past decade.
Topics: Coumarins; Diterpenes; DNA Topoisomerases; Fatty Acids; Flavonoids; Heterocyclic Compounds; Humans; Lignans; Organometallic Compounds; Polyphenols; Quinones; Topoisomerase Inhibitors | 2019 |
Topoisomerase I inhibitors: Challenges, progress and the road ahead.
Topics: Antineoplastic Agents; Camptothecin; DNA Topoisomerases, Type I; Irinotecan; Poisons; Topoisomerase I Inhibitors | 2022 |
12 other study(ies) available for camptothecin and luotonin a
Article | Year |
---|---|
Synthesis and biochemical properties of E-ring modified luotonin A derivatives.
Topics: Enzyme Inhibitors; Humans; Pyrroles; Quinones; Topoisomerase I Inhibitors | 2004 |
Synthesis and topoisomerase poisoning activity of A-ring and E-ring substituted luotonin A derivatives.
Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Enzyme Inhibitors; Humans; Magnetic Resonance Spectroscopy; Pyrroles; Quinones; Spectrometry, Mass, Electrospray Ionization; Topoisomerase I Inhibitors; Topoisomerase II Inhibitors | 2007 |
Design, synthesis and antiproliferative activity of decarbonyl luotonin analogues.
Topics: Antineoplastic Agents; Cell Proliferation; Dose-Response Relationship, Drug; Drug Design; Drug Screening Assays, Antitumor; Humans; Molecular Structure; Pyrroles; Quinones; Structure-Activity Relationship; Tumor Cells, Cultured | 2017 |
A-ring and E-ring modifications of the cytotoxic alkaloid Luotonin A: Synthesis, computational and biological studies.
Topics: Antineoplastic Agents; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Humans; Molecular Docking Simulation; Molecular Structure; Pyrroles; Quinones; Stereoisomerism; Structure-Activity Relationship; Tumor Cells, Cultured | 2020 |
Luotonin A. A naturally occurring human DNA topoisomerase I poison.
Topics: Alkaloids; Antineoplastic Agents, Phytogenic; Camptothecin; DNA; DNA Topoisomerases, Type I; Enzyme Inhibitors; Humans; Pyrroles; Quinones; Topoisomerase I Inhibitors | 2003 |
14-azacamptothecin: a potent water-soluble topoisomerase I poison.
Topics: Camptothecin; Enzyme Inhibitors; Humans; Kinetics; Pyrroles; Quinones; Solubility; Topoisomerase I Inhibitors; Water | 2005 |
Short and efficient total synthesis of luotonin A and 22-hydroxyacuminatine using a common cascade strategy.
Topics: Camptothecin; Chemistry, Organic; Fluorenes; Indolizines; Models, Chemical; Molecular Conformation; Pyrroles; Quinolines; Quinones | 2007 |
Liquid chromatographic analysis of the anticancer alkaloid luotonin A and some new derivatives in human serum samples.
Topics: Alkaloids; Animals; Antineoplastic Agents; Camptothecin; Chromatography, Liquid; Humans; Molecular Structure; Pyrroles; Quinones; Reproducibility of Results | 2010 |
Characterization of in vitro metabolites of luotonin A in human liver microsomes using electrospray/tandem mass spectrometry.
Topics: Biotransformation; Camptothecin; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; DNA, Complementary; Enzyme Inhibitors; Humans; Hydroxylation; Isoenzymes; Metabolic Networks and Pathways; Microsomes, Liver; Molecular Weight; Protons; Pyrroles; Quinones; Recombinant Proteins; Spectrometry, Mass, Electrospray Ionization; Tandem Mass Spectrometry | 2013 |
B-ring-aryl substituted luotonin A analogues with a new binding mode to the topoisomerase 1-DNA complex show enhanced cytotoxic activity.
Topics: Amino Acids; Antineoplastic Agents; Camptothecin; Cerium; Chemistry, Pharmaceutical; Crystallization; DNA; DNA Topoisomerases, Type I; HeLa Cells; Humans; Hydrogen Bonding; Ligands; Magnetic Resonance Spectroscopy; Molecular Conformation; Nitrates; Protein Binding; Pyrroles; Quinones; Topoisomerase I Inhibitors | 2014 |
A theranostic nanocomposite system based on iron oxide-drug nanocages for targeted magnetic field responsive chemotherapy.
Topics: Antineoplastic Agents, Phytogenic; Camptothecin; Cell Proliferation; Drug Delivery Systems; Ferric Compounds; HeLa Cells; Humans; Magnetic Fields; MCF-7 Cells; Nanocomposites; Neoplasms; Pyrroles; Quinones; Theranostic Nanomedicine | 2018 |
D-Ring-Modified Analogues of Luotonin A with Reduced Planarity: Design, Synthesis, and Evaluation of Their Topoisomerase Inhibition-Associated Cytotoxicity.
Topics: Alkaloids; Antineoplastic Agents; Camptothecin; Cell Line, Tumor; DNA Topoisomerases, Type I; DNA Topoisomerases, Type II; Enzyme Inhibitors; Humans; Molecular Docking Simulation; Poly-ADP-Ribose Binding Proteins; Pyrroles; Quinones; Solubility; Structure-Activity Relationship; Topoisomerase Inhibitors | 2019 |